摘要
目的:观察胰岛素泵强化治疗对不同体重指数初诊2型糖尿病胰岛β细胞功能、胰岛素抵抗的影响。方法:将本院收诊的2型糖尿病患者按体重指数分成两组,肥胖组和正常组。所有患者均采用胰岛素泵进行强化治疗,分别于治疗前、治疗2周后、治疗18个月后对胰岛β细胞功能、胰岛素抵抗进行分析。结果:肥胖组患者治疗前后HOMA-β、HOMA-IR均显著高于正常组(P<0.05);治疗2周后,两组患者的HOMA-β、HOMA-IR与疗效基线值相比均显著下降(P<0.05);18个月后随访结果发现,两组患者的HOMA-β、HOMA-IR与疗效基线值相比仍显著下降(P<0.05)。结论:胰岛素泵强化治疗对不同体重指数初诊2型糖尿病胰岛β细胞功能、胰岛素抵抗均有改善作用,而且具有长期缓解作用。
Objective:To observe the effect of insulin pump intensive therapy in βcell function of different body mass index in patients with type 2 diabetes,insulin resistance and long-term remission. Method:Patients with type 2 diabetes in our hospital were divided into two groups according to body mass index:the obesity group and normal group. All patients were treated with insulin pump intensive treatment. 2 weeks before and after treatment, 18 months after treatment,theβcell function and insulin resistance were taken for analysis. Result:The HOMA-β,HOMA-IR in the obesity group before and after treatment in patients were significantly higher than those in the normal group(P 0.05).After 2 weeks of treatment,two groups of patients with HOMA-β,HOMA-IR and efficacy compared to baseline values were significantly decreased(P 0.05);follow-up results after 18 months, patients in the two group,HOMA-β HOMA-IR and efficacy compared to baseline values were significantly decreased(P 0.05).Conclusion:Insulin pump therapy in the treatment of different body mass index in patients has the improving function with newly diagnosed type 2 diabetes isletβcell function, insulin resistance,also has the effect of long-term remission.
出处
《中国医学创新》
CAS
2013年第22期49-50,共2页
Medical Innovation of China
基金
河源市科技计划项目(编号:2012-079)